Recurrent Leiomyosarcoma

Known as: Leiomyosarcoma Recurrent, Relapsed Leiomyosarcoma 
The reemergence of leiomyosarcoma after a period of remission
National Institutes of Health

Topic mentions per year

Topic mentions per year

1973-2017
012319732017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Gemcitabine and docetaxel have been shown to be active in pre-treated relapsed leiomyosarcoma. This study investigated the… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
2014
2014
Leiomyosarcoma may occur anywhere in the body but rarely occurs in the heart or great vessels. Leiomyosarcoma may be managed by… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2009
2009
10527 Background: An objective response rate (RR) of 8% and 17% with G and G+D were respectively reported in metastatic soft… (More)
Is this relevant?
2008
2008
INTRODUCTION Advanced stage/metastatic soft tissue sarcoma (STS) has a poor prognosis especially after failure of the established… (More)
Is this relevant?
2007
2007
OBJECTIVES To evaluate the efficacy and adverse events (AEs) of thalidomide in previously treated, measurable, persistent or… (More)
Is this relevant?
2003
2003
OBJECTIVE The purpose of this phase II trial was to evaluate the efficacy of intravenous paclitaxel in patients with recurrent or… (More)
Is this relevant?
2002
2002
OBJECTIVE This study was conducted to determine the objective response of trimetrexate in patients with advanced or recurrent… (More)
Is this relevant?
1996
1996
Twenty-eight patients with advanced, persistent or recurrent leiomyosarcoma of the uterus not previously exposed to cytotoxic… (More)
Is this relevant?
1992
1992
OBJECTIVE The purpose of this study was to evaluate the activity of ifosfamide (isophosphamide) in patients with advanced or… (More)
Is this relevant?
1986
1986
Twenty patients with advanced or recurrent leiomyosarcoma of the uterus who failed prior chemotherapy were placed on study by the… (More)
Is this relevant?